Skip to content

Clinical trials

Completed Lymphoma, T-Cell, Peripheral trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Status: Completed Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20151
20161
20181
20191
20224

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dizal Pharmaceuticals3
Associazione Angela Serra per la ricerca sul cancro1
BeiGene1
Chipscreen Biosciences, Ltd.1
Mingzhi Zhang1
Mundipharma (China) Pharmaceutical Co. Ltd1
Nanjing Zenshine Pharmaceuticals1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral10
Lymphoma, T-Cell3
Immunoblastic Lymphadenopathy2
Lymphoma, Large-Cell, Anaplastic2
Recurrence2
Leukemia1
Lymphoma1
Lymphoma, Extranodal NK-T-Cell1
Lymphoma, Non-Hodgkin1
Lymphoma, T-Cell, Cutaneous1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.